Stockscreener 앱 받기
8.79
0.46%
0.04
시장 영업 전:
8.61
-0.18
-2.05%
전일 마감가:
$8.75
열려 있는:
$8.73
하루 거래량:
1.18M
Relative Volume:
0.89
시가총액:
$689.59M
수익:
$400.05M
순이익/손실:
$181.01M
주가수익비율:
4.1871
EPS:
2.0993
순현금흐름:
$194.71M
1주 성능:
+15.05%
1개월 성능:
+5.14%
6개월 성능:
-21.94%
1년 성능:
-24.35%
1일 변동 폭
$8.535
$8.89
1주일 범위
$7.58
$8.89
52주 변동 폭
$6.125
$14.96
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
8.79 | 615.85M | 400.05M | 181.01M | 194.71M | 2.0993 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2025-06-30 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Leerink Partners | Outperform |
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2024-08-26 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
Liquidity Mapping Around (CRMD) Price Events - Stock Traders Daily
CRMD,PEP Revenue Breakdown - Finviz
CORMEDIX INC. Files 8-K: Company Details, Stock Info & SEC Filing Summary for June 25, 2026 - Minichart
CorMedix (NASDAQ: CRMD) replaces CBIZ with Ernst & Young as auditor - Stock Titan
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Yahoo Finance
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - TradingView
CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path - TradingView
CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
CorMedix Inc. (CRMD) Slips 2.74% as Stock Tests Support Near $7.25Volatility Smirk - dars.gov.et
CorMedix Inc.(NasdaqGM: CRMD) added to Russell 2000 Value Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Microcap Value Benchmark Index - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
Enterprise value to EBIT forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
Price to book forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Price to sales forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Is Now The Time To Put CorMedix (NASDAQ:CRMD) On Your Watchlist? - Moomoo
Price to earnings forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Form DEF 14A CorMedix Inc For: 25 June - Investing.com UK
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
Form DEF 14A CorMedix Inc For: 25 June By Investing.com - Investing.com Australia
CorMedix Inc. Actuals & Estimates (NASDAQ:CRMD) - TradingView
CRMD Forecast — Price Target — Prediction for 2027 - TradingView
CorMedix (CRMD) shareholders affirm directors but vote down multiple charter amendments - Stock Titan
CorMedix Inc (CRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why (CRMD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Raised 2026 Guidance and DefenCath Momentum Might Change The Case For Investing In CorMedix (CRMD) - simplywall.st
CorMedix Inc (CRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CorMedix Inc. (CRMD) Achieves Remarkable 384.60% Revenue Growth - GuruFocus
CorMedix Inc (CRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CorMedix Inc (CRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CorMedix Inc (CRMD) Institutional Confidence - TradingKey
CorMedix Inc (CRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CorMedix Inc (CRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CorMedix Inc (CRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CorMedix Inc (CRMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
CorMedix (CRMD) Stock Could Be 27.8% Undervalued After Q1 Results And Raised Outlook - Yahoo Finance
The Bull Case For CorMedix (CRMD) Could Change Following Raised 2026 Guidance And DefenCath MomentumLearn Why - Yahoo Finance
CorMedix Inc. (CRMD) Reports Q1 2026 Results - Insider Monkey
CorMedix (CRMD) holder reports 4.62M shares, 5.89% stake - Stock Titan
CorMedix (CRMD): Investor reports 4.62M shares, 5.89% stake - Stock Titan
5 Most Profitable Small Cap Stocks to Buy - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
CRMD Q1 2026 Earnings: EPS Beat of 31.72% Drives Stock HigherProfit Recovery Report - newsline.com
Federal appeals court upholds CorMedix patent win over Nexus - Investing.com UK
Federal Circuit Affirms CorMedix Patent Victory, Blocking Nexus Generic MINOCIN® Launch Until Patent Expiration 1 - minichart.com.sg
Federal appeals court upholds CorMedix patent win over Nexus By Investing.com - Investing.com South Africa
Appeals court upholds CorMedix (NASDAQ: CRMD) MINOCIN® patents and injunction - Stock Titan
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.74%
자본화:
|
볼륨(24시간):